Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate [2]

Journal of Clinical Pathology

Volumn 55, Issue 9, 2002, Pages 718-

  Olukoga, A O ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FATIGUE; HUMAN; HYPERLIPIDEMIA; LETTER; MONOTHERAPY; PRIORITY JOURNAL; XEROSTOMIA;

ANTILIPEMIC AGENTS; BEZAFIBRATE; CHOLESTEROL, HDL; HUMANS; NEPHRITIS, INTERSTITIAL;

EID: 0036724855     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.55.9.718     Document Type: Letter

References (5)

1. A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate
2. Fibrate monotherapy and profound hypoalphalipoproteinaemia
3. Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate
4. Mechanisms of action of fibrates on lipid and lipoprotein metabolism
5. Beneficial effects of fibrates on apolipoprotein A-1 metabolism occur independently of any peroxisome proliferative response